Search results
The FDA tells Covid-19 vaccine makers to update shot to target the variant currently in circulation
CNN.com· 6 days agoThe US Food and Drug Administration announced Friday that it had advised the makers of the Covid-19 ...
Combined flu and Covid jab produces ‘higher immune response’ than separate injections
The Telegraph via Yahoo News· 3 days agoAt the moment, Moderna’s Spikevax vaccine for Covid-19 is used in the NHS booster programmes,...
What to know about upcoming COVID-19 vaccines and the FLiRT variants
GBH News· 7 days agoThe federal government and vaccine makers are getting a new COVID-19 vaccine ready for the fall. An...
COVID-flu combo vaccine shows ‘positive’ results in phase 3 trials, Moderna says: A 'two-for' option
AOL· 3 days agoA combination COVID-influenza vaccine is apparently one step closer to hitting the market. Moderna, which is developing the experimental vaccine ...
Moderna says combo COVID-flu vaccine showing promising results — and more
WGN Chicago via Yahoo News· 3 days agovaccine is showing promising results. Biotech company Moderna says the combination shot was shown to...
Healthy Returns: What we know about the next round of Covid vaccines
CNBC· 2 days agoHere's what we know about the newest vaccines so far. The Food and Drug Administration on Friday...
FDA advisers urge targeting JN.1 strain in recipe for fall's COVID vaccines
WUSF 89.7· 6 days agoGovernment advisers Wednesday said it’s time to update the recipe for the COVID-19 vaccines...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 10 hours agoIn 2020, the industry was thrust into the pandemic limelight as Pfizer and its partner BioNTech,...
Moderna's two-in-one flu and Covid vaccine passes advanced trial
BBC News· 4 days agoDrug company Moderna says its combined flu and Covid vaccine, which targets the two diseases in a...
Bridgeway Capital Management LLC Boosts Stock Position in Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 19 hours agoBridgeway Capital Management LLC boosted its holdings in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 26.0% during the 4th quarter, according to its most recent 13F filing ...